Cc1ccc(C)c(N2CCN(S(=O)(=O)c3c(C(=O)N4CCC(C)CC4)c(C)n(C)c3C)CC2)c1
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?